217.03
-9.51
(-4.20%)
As of 10:32:25 AM EDT. Market Open.
Breakdown
TTM
1/31/2025
1/31/2024
1/31/2023
1/31/2022
Total Revenue
2,746,619
2,746,619
2,363,673
2,155,060
1,850,777
Cost of Revenue
699,636
699,636
677,291
609,405
503,678
Gross Profit
2,046,983
2,046,983
1,686,382
1,545,655
1,347,099
Operating Expense
1,355,548
1,355,548
1,257,048
1,086,564
841,603
Operating Income
691,435
691,435
429,334
459,091
505,496
Net Non Operating Interest Income Expense
207,987
207,987
133,748
45,860
14,730
Other Income Expense
19,959
19,959
24,941
4,145
-7,915
Pretax Income
919,381
919,381
588,023
509,096
512,311
Tax Provision
205,243
205,243
62,318
21,390
84,921
Net Income Common Stockholders
714,138
714,138
525,705
487,706
427,390
Diluted NI Available to Com Stockholders
714,138
714,138
525,705
487,706
427,390
Basic EPS
4.41
4.41
3.27
3.14
2.79
Diluted EPS
4.32
4.32
3.22
3.00
2.63
Basic Average Shares
161,879
161,879
160,532
155,385
153,251
Diluted Average Shares
165,232
165,232
163,486
162,437
162,277
Total Operating Income as Reported
691,435
691,435
429,334
459,091
505,496
Total Expenses
2,055,184
2,055,184
1,934,339
1,695,969
1,345,281
Net Income from Continuing & Discontinued Operation
714,138
714,138
525,705
487,706
427,390
Normalized Income
716,681.90
716,681.90
525,594.14
487,139.83
427,985.65
Interest Income
207,987
207,987
133,748
45,860
14,730
Net Interest Income
207,987
207,987
133,748
45,860
14,730
EBIT
691,435
691,435
429,334
459,091
505,496
EBITDA
730,818
730,818
461,962
488,213
532,944
Reconciled Cost of Revenue
699,636
699,636
677,291
609,405
503,678
Reconciled Depreciation
39,383
39,383
32,628
29,122
27,448
Net Income from Continuing Operation Net Minority Interest
714,138
714,138
525,705
487,706
427,390
Total Unusual Items Excluding Goodwill
-3,274
-3,274
124
591
-714
Total Unusual Items
-3,274
-3,274
124
591
-714
Normalized EBITDA
734,092
734,092
461,838
487,622
533,658
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-730.10
-730.10
13.14
24.83
-118.35
1/31/2022 - 10/16/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DOCS Doximity, Inc.
53.90
-6.99%
GEHC GE HealthCare Technologies Inc.
72.09
-9.16%
TDOC Teladoc Health, Inc.
7.38
-5.32%
HQY HealthEquity, Inc.
83.09
-6.37%
CERT Certara, Inc.
9.62
-5.96%
TEM Tempus AI, Inc.
47.67
-4.45%
SDGR Schrödinger, Inc.
18.38
-7.55%
WAY Waystar Holding Corp.
35.96
-3.68%
TXG 10x Genomics, Inc.
8.11
-8.37%
PRVA Privia Health Group, Inc.
22.06
-1.34%